Por una salud de calidad y calidez
On April 13, 2021, CDC and FDA recommended a pause in the use of Johnson & Johnson’s Janssen COVID-19 Vaccine. Of the nearly 7 million doses administered so far in the United States, a small number of reports of a rare and severe type of blood clot have been reported […]
On April 13, the CDC and the FDA issued a joint statement recommending a pause in Johnson & Johnson vaccine administration, pending review of six reported US cases of a rare and severe type of blood clot occurring after receiving the Johnson & Johnson vaccine. To date, more than 6.8 million doses of […]
As potentially more dangerous coronavirus variants spread worldwide, scientists and clinicians have raced to discover how well the available COVID-19 vaccines protect against the mutant strains. Preliminary results from a large study of health care workers now suggest one dose of CoronaVac, a vaccine developed by a Chinese company, is […]
The FDA and CDC on Tuesday recommended that use of the Johnson & Johnson COVID-19 be paused after reports of blood clots in patients receiving the shot, the FDA and CDC announced Tuesday. In a statement, FDA said 6.8 million doses of the J&J vaccine have been administered and the […]
The US, South Africa and European Union will temporarily stop the rollout of the Johnson & Johnson (J&J) Covid jab, after reports of rare blood clotting. Six cases were detected in more than 6.8 million doses of the vaccine, the US Food and Drug Administration (FDA) said. Johnson & Johnson […]
The global effort to develop safe and effective Covid-19 vaccines has yielded remarkable results, owing in part to early, decisive investments in clinical discovery through efforts such as Operation Warp Speed. These achievements highlight the payoff of stable, long-term support of basic research and immunology: our scientific community was prepared […]
The efficacy of two injections of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike messenger RNA (mRNA) vaccines (BNT162b2 [Pfizer] and mRNA-1273 [Moderna])1 in preventing symptomatic SARS-CoV-2 infection in persons without previous coronavirus disease 2019 (Covid-19) has been shown to be high. We wondered what the response would be to the […]
The European Medicines Agency continues to reassure the public about the safety of the AstraZeneca COVID-19 vaccine, although several countries have imposed new restrictions on the product, owing to its link to a rare clotting disorder. Use of the vaccine has been suspended for individuals younger than 55 or 60 […]
A small number of people have tested positive for COVID-19 more than two weeks after being fully vaccinated, which is also known as a “breakthrough” case. The two-week mark is important because the body needs enough time to develop immunity, according to Prevention. So far, those with breakthrough cases have reported […]
Phase III clinical trials show that Pfizer’s coronavirus vaccine is 100% effective in protecting children 12-15 years old from infection, the company said in a news release. The study enrolled 2,260 adolescents ages 12-15. No infections were reported in the group given the vaccine produced by Pfizer and its European […]